Thermo Fisher Scientific Inc. acquired IntegenX Inc., a Pleasanton, Calif.-based provider of rapid DNA testing tools.
Financial terms of the deal were not disclosed.
Prosecutors and law enforcement in 17 countries use IntegenX's platform, Thermo Fisher said in a news release. The Waltham, Mass.-based life sciences company plans to combine IntegenX technology with its own chemistries to help expand its position in the human identification market, in addition to enhancing its existing human identification portfolio.
Rapid DNA platforms can produce standardized profiles in less than two hours, simplifying and accelerating forensic processes.
